DOSSIER · UPDATED 18 NOV 2025

858 Therapeutics

858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecule drugs that act on novel therapeutic targets in oncology, including proteins that regulate RNA and the innate immune response.

8five8tx.com ↗Claim this profile

Founded: 2019
Headcount: 34
Open roles: 0
Last raised: Series B · $50M

SECTION I · THE BRIEF

Inside 858 Therapeutics

Brief #77593Updated 18 NOV 2025SAN DIEGOMEDICAL ORGANIZATIONSSERIES B

Employbl Dossier

858 Therapeutics

Founded: 2019
Headcount: 34
Open roles: 0
Last raised: Series B · $50M

Section II · Premium ProfileMembers only

01Engineering interview process at 858 TherapeuticsLocked
02Tech stack & infrastructure choicesLocked
03Culture & day-to-day work styleLocked
04Why join now vs. 6 months from nowLocked
05Hiring focus & open headcount by teamLocked
06Comp philosophy and band contextLocked

Open 858 Therapeutics brief Sign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Jeffrey Stafford

Gretchen Bain

Jim Veal

OPEN ROLES

Hiring at 858 Therapeutics

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total Amount Raised: $130,056,096